Concepedia

Efrat Resnick

ER

13

Publications

1.6K

Citations

12

H-Index

2018

Active since

Affiliations

Weizmann Institute of Science(Current)

Diamond Light Source

University of Johannesburg

University of Oxford

Research Complex at Harwell

Efrat Resnick is an author at Weizmann Institute of Science specializing in medicine, molecular biology, and drug discovery.

Top concepts

MedicineDrug DiscoveryNatural SciencesMolecular BiologyBiochemistryChemical BiologyChemistryPharmacologyMolecular DockingProtein Engineering

Publications per year

2018–2023

13

Publications

13

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

A. Douangamath, D. Fearon, Paul Gehrtz et al. · Nature Communications · 2020 · 527 citations · Full text

Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening

Efrat Resnick, A.R. Bradley, Jinrui Gan et al. · Journal of the American Chemical Society · 2019 · 323 citations · Full text

Chemical Biology, Selective Probes, Biochemistry +15

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, D. Fearon, Matteo P. Ferla et al. · Science · 2023 · 158 citations · Full text

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa et al. · Nature Chemical Biology · 2021 · 141 citations · Full text

Covalent Inhibitor, Oncology, Malignant Disease +9

Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry

Rambabu Reddi, Efrat Resnick, Adi Rogel et al. · Journal of the American Chemical Society · 2021 · 92 citations · Full text

Rows per page

1–5 of 13